FULGENT GENETICS, INC. Operating Expenses
FULGENT GENETICS, INC. (FLGT) reported Operating Expenses of $61.75 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-07-30
- FULGENT GENETICS, INC. operating expenses for the quarter ending 2026-06-30 was $61.75M, a 14.04% increase year-over-year.
- FULGENT GENETICS, INC. operating expenses for the quarter ending 2026-03-31 was $56.11M, a 16.56% increase year-over-year.
- FULGENT GENETICS, INC. operating expenses for the quarter ending 2025-12-31 was $68.82M, a 43.42% increase year-over-year.
- FULGENT GENETICS, INC. operating expenses for the quarter ending 2025-09-30 was $50.86M, a 15.99% increase year-over-year.
- FULGENT GENETICS, INC. operating expenses for fiscal 2025 was $221.97M, a 22.55% increase from fiscal 2024.
- FULGENT GENETICS, INC. operating expenses for fiscal 2024 was $181.13M, a 39.62% decline from fiscal 2023.
- FULGENT GENETICS, INC. operating expenses for fiscal 2023 was $299.99M, a 59.25% increase from fiscal 2022.
- FULGENT GENETICS, INC. operating expenses for fiscal 2022 was $188.37M, a 86.33% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $61.75M 10-Q · filed 2026-07-30 | $117.86M 10-Q · filed 2026-07-30 | $186.68M derived: sum of 3 quarters · filed 2026-07-30 | $237.55M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $56.11M 10-Q · filed 2026-05-01 | $124.93M derived: sum of 2 quarters · filed 2026-05-01 | $175.79M derived: sum of 3 quarters · filed 2026-05-01 | $229.94M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $68.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $119.68M derived: sum of 2 quarters · filed 2026-02-27 | $173.83M derived: sum of 3 quarters · filed 2026-07-30 | $221.97M 10-K · filed 2026-02-27 |
| 2025-09-30 | $50.86M 10-Q · filed 2025-11-07 | $105.01M derived: sum of 2 quarters · filed 2026-07-30 | $153.15M 10-Q · filed 2025-11-07 | $201.13M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $54.15M 10-Q · filed 2026-07-30 | $102.29M 10-Q · filed 2026-07-30 | $150.27M derived: sum of 3 quarters · filed 2026-07-30 | $194.12M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $48.14M 10-Q · filed 2026-05-01 | $96.13M derived: sum of 2 quarters · filed 2026-05-01 | $139.97M derived: sum of 3 quarters · filed 2026-05-01 | $185.37M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $47.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $91.83M derived: sum of 2 quarters · filed 2026-02-27 | $137.23M derived: sum of 3 quarters · filed 2026-02-27 | $181.13M 10-K · filed 2026-02-27 |
| 2024-09-30 | $43.85M 10-Q · filed 2025-11-07 | $89.25M derived: sum of 2 quarters · filed 2025-11-07 | $133.15M 10-Q · filed 2025-11-07 | $309.50M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $45.40M 10-Q · filed 2025-08-01 | $89.30M 10-Q · filed 2025-08-01 | $265.65M derived: sum of 3 quarters · filed 2026-02-27 | $305.28M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $43.90M 10-Q · filed 2025-05-02 | $220.25M derived: sum of 2 quarters · filed 2026-02-27 | $259.88M derived: sum of 3 quarters · filed 2026-02-27 | $300.25M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $176.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $215.98M derived: sum of 2 quarters · filed 2026-02-27 | $256.35M derived: sum of 3 quarters · filed 2026-02-27 | $299.99M 10-K · filed 2026-02-27 |
| 2023-09-30 | $39.63M 10-Q · filed 2024-11-08 | $80.00M derived: sum of 2 quarters · filed 2024-11-08 | $123.64M 10-Q · filed 2024-11-08 | $173.17M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $40.37M 10-Q · filed 2024-08-02 | $84.00M 10-Q · filed 2024-08-02 | $133.54M derived: sum of 3 quarters · filed 2024-08-02 | $179.29M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $43.63M 10-Q · filed 2024-05-03 | $93.17M derived: sum of 2 quarters · filed 2024-05-03 | $138.92M derived: sum of 3 quarters · filed 2024-05-03 | $191.40M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $49.54M 10-K · filed 2023-02-28 | $95.28M derived: sum of 2 quarters · filed 2023-11-03 | $147.76M derived: sum of 3 quarters · filed 2023-11-03 | $188.37M 10-K · filed 2025-02-28 |
| 2022-09-30 | $45.74M 10-Q · filed 2023-11-03 | $98.22M derived: sum of 2 quarters · filed 2023-11-03 | $138.84M 10-Q · filed 2023-11-03 | $177.51M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $52.48M 10-Q · filed 2023-08-04 | $93.09M 10-Q · filed 2023-08-04 | $131.77M derived: sum of 3 quarters · filed 2023-08-04 | $156.90M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $40.61M 10-Q · filed 2023-05-05 | $79.29M derived: sum of 2 quarters · filed 2023-05-05 | $104.42M derived: sum of 3 quarters · filed 2023-05-05 | $123.28M derived: sum of 4 quarters · filed 2023-05-05 |
| 2021-12-31 | $38.68M 10-K · filed 2023-02-28 | $63.81M derived: sum of 2 quarters · filed 2023-02-28 | $82.67M derived: sum of 3 quarters · filed 2023-02-28 | $101.10M 10-K · filed 2024-02-28 |
| 2021-09-30 | $25.13M 10-K · filed 2023-02-28 | $43.99M derived: sum of 2 quarters · filed 2023-02-28 | $62.42M 10-Q · filed 2022-11-07 | $79.72M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $18.86M 10-K · filed 2023-02-28 | $37.29M 10-Q · filed 2022-08-04 | $54.59M derived: sum of 3 quarters · filed 2023-02-28 | $66.52M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $18.43M 10-K · filed 2023-02-28 | $35.73M derived: sum of 2 quarters · filed 2023-02-28 | $47.66M derived: sum of 3 quarters · filed 2023-02-28 | $54.57M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $17.30M 10-K · filed 2022-02-28 | $29.23M derived: sum of 2 quarters · filed 2022-02-28 | $36.14M derived: sum of 3 quarters · filed 2022-02-28 | $41.75M 10-K · filed 2023-02-28 |
| 2020-09-30 | $11.93M 10-K · filed 2022-02-28 | $18.84M derived: sum of 2 quarters · filed 2022-02-28 | $24.45M 10-Q · filed 2021-11-09 | $29.61M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $6.91M 10-K · filed 2022-02-28 | $12.52M 10-Q · filed 2021-08-10 | $17.68M derived: sum of 3 quarters · filed 2022-02-28 | $22.63M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $5.61M 10-K · filed 2022-02-28 | $10.77M derived: sum of 2 quarters · filed 2022-02-28 | $15.72M derived: sum of 3 quarters · filed 2022-02-28 | $20.23M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $5.16M 10-K · filed 2021-03-08 | $10.12M derived: sum of 2 quarters · filed 2021-03-08 | $14.62M derived: sum of 3 quarters · filed 2021-03-08 | $18.85M 10-K · filed 2022-02-28 |
| 2019-09-30 | $4.95M 10-K · filed 2021-03-08 | $9.46M derived: sum of 2 quarters · filed 2021-03-08 | $13.69M 10-Q · filed 2020-11-09 | $17.62M derived: sum of 4 quarters · filed 2021-03-08 |
| 2019-06-30 | $4.51M 10-K · filed 2021-03-08 | $8.73M 10-Q · filed 2020-08-05 | $12.67M derived: sum of 3 quarters · filed 2021-03-08 | $16.53M derived: sum of 4 quarters · filed 2021-03-08 |
| 2019-03-31 | $4.22M 10-K · filed 2021-03-08 | $8.16M derived: sum of 2 quarters · filed 2021-03-08 | $12.02M derived: sum of 3 quarters · filed 2021-03-08 | $15.87M derived: sum of 4 quarters · filed 2021-03-08 |
| 2018-12-31 | $3.93M 10-K · filed 2020-03-13 | $7.79M derived: sum of 2 quarters · filed 2020-03-13 | $11.65M derived: sum of 3 quarters · filed 2020-03-13 | $15.72M 10-K · filed 2020-03-13 |
| 2018-09-30 | $3.86M 10-K · filed 2020-03-13 | $7.72M derived: sum of 2 quarters · filed 2020-03-13 | $11.79M 10-Q · filed 2019-11-08 | $15.60M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-06-30 | $3.86M 10-K · filed 2020-03-13 | $7.93M 10-Q · filed 2019-08-12 | $11.74M derived: sum of 3 quarters · filed 2020-03-13 | $15.45M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-03-31 | $4.08M 10-K · filed 2020-03-13 | $7.88M derived: sum of 2 quarters · filed 2020-03-13 | $11.60M derived: sum of 3 quarters · filed 2020-03-13 | $14.51M derived: sum of 4 quarters · filed 2020-03-13 |
| 2017-12-31 | $3.81M 10-K · filed 2019-03-22 | $7.52M derived: sum of 2 quarters · filed 2019-03-22 | $10.43M derived: sum of 3 quarters · filed 2019-03-22 | $13.66M 10-K · filed 2019-03-22 |
| 2017-09-30 | $3.72M 10-K · filed 2019-03-22 | $6.63M derived: sum of 2 quarters · filed 2019-03-22 | $9.86M 10-Q · filed 2018-11-09 | $12.59M derived: sum of 4 quarters · filed 2019-03-22 |
| 2017-06-30 | $2.91M 10-K · filed 2019-03-22 | $6.14M 10-Q · filed 2018-08-13 | $8.87M derived: sum of 3 quarters · filed 2019-03-22 | $12.43M derived: sum of 4 quarters · filed 2019-03-22 |
| 2017-03-31 | $3.23M 10-K · filed 2019-03-22 | $5.96M derived: sum of 2 quarters · filed 2019-03-22 | $9.52M derived: sum of 3 quarters · filed 2019-03-22 | $11.11M derived: sum of 4 quarters · filed 2019-03-22 |
| 2016-12-31 | $2.73M 10-K · filed 2018-03-20 | $6.29M derived: sum of 2 quarters · filed 2018-03-20 | $7.88M derived: sum of 3 quarters · filed 2018-03-20 | $10.64M 10-K · filed 2018-03-20 |
| 2016-09-30 | $3.56M 10-K · filed 2018-03-20 | $5.15M derived: sum of 2 quarters · filed 2018-03-20 | $7.90M 10-Q · filed 2017-11-13 | $15.42M derived: sum of 4 quarters · filed 2018-03-20 |
| 2016-06-30 | $1.59M 10-K · filed 2018-03-20 | $4.34M 10-Q · filed 2017-08-14 | $11.86M derived: sum of 3 quarters · filed 2018-03-20 | $12.67M derived: sum of 4 quarters · filed 2018-03-20 |
| 2016-03-31 | $2.75M 10-K · filed 2018-03-20 | $10.27M derived: sum of 2 quarters · filed 2018-03-20 | $11.08M derived: sum of 3 quarters · filed 2018-03-20 | $11.74M derived: sum of 4 quarters · filed 2018-03-20 |
| 2015-12-31 | $7.52M 10-K · filed 2017-03-17 | $8.33M derived: sum of 2 quarters · filed 2017-03-17 | $8.99M derived: sum of 3 quarters · filed 2017-03-17 | $9.52M 10-K · filed 2017-03-17 |
| 2015-09-30 | $807.00K 10-K · filed 2017-03-17 | $1.47M derived: sum of 2 quarters · filed 2017-03-17 | $2.00M 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $663.00K 10-K · filed 2017-03-17 | $1.19M derived: sum of 2 quarters · filed 2017-03-17 | ||
| 2015-03-31 | $530.00K 10-K · filed 2017-03-17 | |||
| 2014-12-31 | $1.33M 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |